glp-1 news nov 2025 dominates for trial activity GLP-1s: The Swiss Army Knife

Direct-to-consumer advertising has elevated patient demand, while robust clinical and prescribing ecosystems make the U.S

Continue to prioritize other essential aspects of well-being, such as therapy, healthy diet, regular exercise, and strong social support, alongside any medication

It has shown the potential to promote significant weight loss and improve glycemic control in clinical trials

Some researchers studying metabolic parameters specifically choose to maintain at 8mg rather than escalating further, allowing for longer protocol durations with the same vial supply

The bottom line is that CRNAs must be hyper-vigilant in caring for patients prescribed GLP-1RAs

Do not use Wegovy, Ozempic, Zepbound, or Compounded Liraglutide if you are currently pregnant, breastfeeding, or plan to become pregnant or breastfeed